Population
Children with hypertension
Design
Review
Authors
Loading...
May constrain evidence-based prescribing in children; leaves open whether incentives have spurred needed pediatric trials.
Highlights the critical lack of pediatric data for antihypertensive medications and outlines regulatory incentives (FDA Modernization Act) designed to stimulate pediatric clinical trials.
Thomas G. Wells (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: